These results suggest that PEI-GOS-PEG-FA-Rho has efficient tumor-targeting effects; in contrast, the results of the PEI-GOS-PEG-Rho and free Rho tests show limited tumor uptake in the absence of the targeting ligand. This evidence concerns the gene RHO and neoplasm.